These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 19788294)

  • 1. Fluorine bonding--how does it work in protein-ligand interactions?
    Zhou P; Zou J; Tian F; Shang Z
    J Chem Inf Model; 2009 Oct; 49(10):2344-55. PubMed ID: 19788294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-X...H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity.
    Lu Y; Wang Y; Xu Z; Yan X; Luo X; Jiang H; Zhu W
    J Phys Chem B; 2009 Sep; 113(37):12615-21. PubMed ID: 19708644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine in protein environments: a QM and MD study.
    Samsonov SA; Salwiczek M; Anders G; Koksch B; Pisabarro MT
    J Phys Chem B; 2009 Dec; 113(51):16400-8. PubMed ID: 19947631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen bonding interactions of covalently bonded fluorine atoms: from crystallographic data to a new angular function in the GRID force field.
    Carosati E; Sciabola S; Cruciani G
    J Med Chem; 2004 Oct; 47(21):5114-25. PubMed ID: 15456255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halogen bonding--a novel interaction for rational drug design?
    Lu Y; Shi T; Wang Y; Yang H; Yan X; Luo X; Jiang H; Zhu W
    J Med Chem; 2009 May; 52(9):2854-62. PubMed ID: 19358610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design.
    Lu Y; Wang Y; Zhu W
    Phys Chem Chem Phys; 2010 May; 12(18):4543-51. PubMed ID: 20428531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants for ATP-binding in proteins: a data mining and quantum chemical analysis.
    Mao L; Wang Y; Liu Y; Hu X
    J Mol Biol; 2004 Feb; 336(3):787-807. PubMed ID: 15095988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ab initio investigation of the complexes between bromobenzene and several electron donors: some insights into the magnitude and nature of halogen bonding interactions.
    Lu YX; Zou JW; Wang YH; Jiang YJ; Yu QS
    J Phys Chem A; 2007 Oct; 111(42):10781-8. PubMed ID: 17918810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are AM1 ligand-protein binding enthalpies good enough for use in the rational design of new drugs?
    Villar R; Gil MJ; García JI; Martínez-Merino V
    J Comput Chem; 2005 Oct; 26(13):1347-58. PubMed ID: 16021597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QM methods in structure based design: utility in probing protein-ligand interactions.
    Gleeson MP; Hannongbua S; Gleeson D
    J Mol Graph Model; 2010 Dec; 29(4):507-17. PubMed ID: 21075029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Fluoropiperidines and N-methyl-3-fluoropiperidinium salts: the persistence of axial fluorine.
    Sun A; Lankin DC; Hardcastle K; Snyder JP
    Chemistry; 2005 Feb; 11(5):1579-91. PubMed ID: 15662680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantum chemical associations ligand-residue: their role to predict flavonoid binding sites in proteins.
    Rolo-Naranjo A; Codorniu-Hernández E; Ferro N
    J Chem Inf Model; 2010 May; 50(5):924-33. PubMed ID: 20373791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between performance of QM/MM docking and simple classification of binding sites.
    Chung JY; Hah JM; Cho AE
    J Chem Inf Model; 2009 Oct; 49(10):2382-7. PubMed ID: 19799409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B; Mohr P; Stahl M
    J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accurate assessment of the strain energy in a protein-bound drug using QM/MM X-ray refinement and converged quantum chemistry.
    Fu Z; Li X; Merz KM
    J Comput Chem; 2011 Sep; 32(12):2587-97. PubMed ID: 21598285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine in medicinal chemistry.
    Böhm HJ; Banner D; Bendels S; Kansy M; Kuhn B; Müller K; Obst-Sander U; Stahl M
    Chembiochem; 2004 May; 5(5):637-43. PubMed ID: 15122635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of protein-ligand interaction energies by a fragmentation approach combining high-level quantum chemistry with classical many-body effects.
    Söderhjelm P; Aquilante F; Ryde U
    J Phys Chem B; 2009 Aug; 113(32):11085-94. PubMed ID: 19618955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
    Pierce AC; Sandretto KL; Bemis GW
    Proteins; 2002 Dec; 49(4):567-76. PubMed ID: 12402365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated ligand placement and refinement with a combined force field and shape potential.
    Wlodek S; Skillman AG; Nicholls A
    Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):741-9. PubMed ID: 16790930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing complexes with F-Li+-F lithium bonds: structures, binding energies, and spin-spin coupling constants.
    Del Bene JE; Alkorta I; Elguero J
    J Phys Chem A; 2009 Jul; 113(29):8359-65. PubMed ID: 19569706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.